Isomorphic Labs is reimagining the entire drug discovery process from first principles with an AI-first approach.
Sector
Life Sciences
Date Invested
2025
Investor
Krishna Yeshwant (left)
First Round
Series A
Founder & CEO
Sir Demis Hassabis, PhD (right)
Website